Search Results for statin

... as an emerging cardiovascular risk factor. PD patients exhibit a more overtly abnormal lipid profile than HD patients, probably due to the metabolic interference of the peritoneal dialysis fluid. Statins are the main drugs for the treatment of dyslipidemia and they are able to decrease all LDL subclasses levels...

... understood, but both the protein loss in the dialysate, and the glucose absorption from the dialysate may contribute to these alterations. Hydroxymethylglutaryl coenzyme A reductase inhibitors, more commonly known as statins, are effective to reduce low density cholesterol levels in PD patients and have few...

... and the glucose absorption from the dialysate may contributes to these alterations. Hydroxymethylglutaryl coenzyme A reductase inhibitors, more commonly known as statins, are effective to reduce low density cholesterol levels in PD patients, but so far no large studies has been performed concerning the effects...

... of the same properties in terms of activation of pro-inflammatory,pro-oxidant and pro-atherosclerosis pathways. Statins in particular have been shownto influence the biology of endothelial cells, vascular smooth muscle cells and constituentsof the interstitial matrix, particularly fibroblasts. It is no wonder...

... Abstract Evidence of the effectiveness of 3-hydroxy-3-methylglutaryl coenzyme A reductaseinhibitors (statins) within continuum of atherothrombotic conditions and particularly in the treatmentand prevention of coronary heart disease (CHD) is well established. Large-scale, randomized,prospective...

... rates of LDL. The reviews some of the biochemistry of lipids in uremia and discusses the randomized trial data that support these statements and provides greater detail regarding use of statin in patients with stages 4 and 5 CKD. Caution should be used in dosing statins in stage 3b or higher CKD...

... of cholesterol by skeletal muscle after exercise, the impact of dietary cholesterol, and the fate of cholesterol (membrane, steroids, etc.) remain to be determined. Model of skeletal muscle hypertrophy with proposed effects of statins, cholesterol and lipid rafts. © = Influence of cholesterol; ş = influence...

... muscle actions. J Sports Med Phys Fit 2004;44:193-199 8. Riechman SE, Kean D, Andrews RD, Gasier H, Hammer S: Dietary cholesterol alters recovery from eccentric muscle damage in humans. Med Sci Sports Exerc 2006;38:S368 9. Riechman SE, Andrews R, MacLean DA: Statins and dietary and blood...

... 2012;2:58-67. 17. Dixon JB, Zimmet P, Alberti KG, Rubino F: Bariatric surgery: an IDF statement for obese type 2 diabetes. Arq Bras Endocrinol Metabol 2011;55:367-382. 18. Ginsberg HN: Review: efficacy and mechanisms of action of statins in the treatment of diabetic dyslipidemia. J Clin...

.... However, there is little additional benefit regarding weight loss and its cost should be considered against a program of eating and behavioral modification. Dyslipidemia and the Metabolic Syndrome Statins Statins reduce plasma LDL-c levels and have moderate effects on TG and HDL-c levels...

...References References 1. Prichard SS: Management of hyperlipidemia in patients on peritoneal dialysis: current approaches. Kidney Int 2006;(suppl 103)S115-S117 2. Epstein M, Vaziri ND: Statins in the management of dyslipidemia associated with chronic kidney disease. Nat Rev Nephrol 2012...

... termination of JUPITER, a trial testing rosuvastatin, presumably the most effective statin in terms of cholesterol lowering, against a placebo in the primary prevention of CHD [ 13 , 14 ]. With this announcement, investigators probably wanted to communicate that rosuvastatin, contrary to ezetimibe...

... the recommendations. Indeed, the ‘Guidelines for the Diagnosis and Prevention of Atherosclerotic Disease - 2007’, issued by the Japan Atherosclerotic Society and ten related medical societies, included this concept citing more than 500 medical papers worldwide. The reported effectiveness of statins, cholesterol...

..., Verschuren WM, Klungel OH: Dose-dependent cholesterol-lowering effects of phytosterol/phytostanol-enriched margarine in statin users and statin non-users under free-living conditions. Public Health Nutr 2011;14:1823-1832. 6. Malhotra A, Shafiq N, Arora A, Singh M, Kumar R, Malhotra S: Dietary...

... of statin pleiotropic effects: hypotheses versus evidence. Circulation 2005;111:2280-2281 32. Nissen JE: Courage under fire: what is the optimal approach to initial treatment of stable angina?. Curr Cardiol Rep 2008;10:79-80 33. Nissen SE, Tuzcu EM, Schoenhagen P, et al: Effect of intensive compared...

.... Treatment: For “CKD and CHD” we discuss the association of CKD and CHD in community-based populations, traditional risk factor in CKD, non-traditional risk factor in CKD, reduced risk of CHD in patients with CKD, statin treatment, hypertension treatment, anti-platelet aggregation therapy, treatment of CHD...

... that current practice misses a considerable number of individuals with abnormal LDL levels. This year the Cochrane Library published a review on the safety and benefits of statin treatment in children. In addition, we learn about the effect of maternal hyperlipidemia during pregnancy on fetal programming...

... demonstrating the benefit of common interventions, such as statin treatment for dyslipidemia,improvement of HbA1c levels in diabetic patients, implementation of physical exercise,normalization of Hgb and achievement of adequate dry weight in dialysis patients. Thisarticle gives an overview of modifiable...

.... Therapeutic interventions in PCOS women based on lifestyle modification as well as use of insulin sensitizers did not show significant effect on dyslipidemia. Statins are considered to be a group of promising agents that are safe and effective in improving total cholesterol, LDL cholesterol and triglycerides...